Your existing Tirzepatide script does not carry over
Tesamorelin (Egrifta) is FDA-approved for HIV-associated lipodystrophy
GLP-1 drugs work by promoting satiety, reducing food intake, and thus decreasing body weight and blood pressure
Individual results vary and any decisions you make based on this content are your own responsibility Supplement Rundown: What Works, What's a Waste, When to Switch I have been a fitness coach for 8 years and I'm here to teach you what it takes to finally lose that weight and be the best version of yourself
After 36 weeks, the 0.5 mg retatrutide group showed a 3.19% body weight reduction, the 4 mg group showed a 10.37% decrease, the 8 and 12 mg groups demonstrated decreases of 16.81% and 16.94% respectively, which were significantly greater than those observed with placebo (3.00%) and 1.5 mg dulaglutide (2.02%) [114]
Doxorubicin (DOX)-induced cardiac injury (DIC)(Fig